ArticleRespiratory medicine case reports2026
Severe pulmonary disease as a driver of dynamic left ventricular outflow tract obstruction in stress cardiomyopathy.
Article in Respiratory medicine case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dynamic left ventricular outflow tract obstruction (LVOTO) is a recognized complication of stress cardiomyopathy and can mimic hypertrophic obstructive cardiomyopathy (HOCM) even in the absence of structural hypertrophy. In critically ill patients with severe pulmonary disease, preload, afterload, and contractility can be altered which may exacerbate obstruction. Case presentation: A 76-year-old woman with interstitial lung disease and microscopic polyangiitis receiving immunosuppressive therapy presented with progressive dyspnea and shock. Transthoracic echocardiography demonstrated systolic anterior motion (SAM) of the mitral valve and a dynamic LVOT gradient which increased with Valsalva maneuver. Coronary angiography showed no obstructive coronary artery disease. Cardiac magnetic resonance imaging demonstrated normal left ventricular wall thickness with hypokinesis of the mid-to-apical segments suggestive of stress cardiomyopathy. Her clinical course was complicated by COVID-19 pneumonia, recurrent shock, mechanical ventilation, and progressive right ventricular dysfunction. Repeat echocardiography demonstrated persistent dynamic obstructive physiology despite the absence of structural cardiac disease. Treatment required careful preload optimization, vasopressor selection, and respiratory support, as interventions commonly used for shock and pulmonary edema risked worsening LVOTO. Conclusion: This case highlights stress cardiomyopathy complicated by dynamic LVOTO presenting with pseudo-HOCM physiology. Clinical complications of severe pulmonary disease, respiratory failure, and right ventricular dysfunction likely amplified the preload-dependent obstruction and contributed to refractory hemodynamic instability. Due to standard shock therapies paradoxically worsening obstruction, early echocardiographic recognition and physiology-guided management are critical in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.